Three breast cancer cell lines, including HER2 protein overexpressing breast cancer cell (BT474), HER2− control (MCF-10A), and HER2+ control (MCF-10A/HER2), were investigated by RM. This evidence concerns the gene ERBB2 and breast carcinoma.